WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Osteoporosis Efficacy Criteria v9, Dual energy x-ray absorptiometry (DXA) performed at Time points defined by protocol, T-score assessed only secondarily for 1/3 distal radius, FDA Efficacy Criteria for Osteoporosis additional variables for efficacy consideration Concomitant Medications, Concomitant Medications instantiated_by Concomitant Medications, Radiographic Report include Type of fracture, pain measured by VAS, Blood for serum biomarkers, Radiographic Test performed at Time points defined by protocol, Fracture Healing represented by X-ray measures, Biochemical markers of bone turnover obtained from testing Urine, Radiographic Test classified by Quantitative Morphometry, T-score measured in units Standard Deviations (SD), Radiographic healing can be - Yes - No, Radiographic Test performed at Time Points defined by symptoms, Concepts are denoted by solid round-edged rectangle, Non-vertebral fracture is confirmed by Radiographic Test, T-score assessed primarily and secondarily for - lumbar vertebrae - total hip - femoral neck, Semi-Quantitative Assessment assesses Vertebral shape, Semi-Quantitative Assessment measured for vertebrae T4 - L5, Biochemical markers of bone turnover obtained from testing Blood